CALGARY, AB, June 17, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSX-V: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce the launch of its high-end concentrate brand, “Pressed by Qwest“, and new dried flower, pre-roll, vape, and concentrate products.

“The launch of Pressed by Qwest marks our first step into the premium concentrate category, mirroring our approach with Qwest in dried flower, we are bringing rare cultivars, high-standard craft quality, and choice to consumers.” said Cody Church, Interim Chief Executive Officer of Decibel. “Our strategic focus remains on expanding our market share as we launch our premium cannabis 2.0 products and increasing our flower capacity from 1,800 kg to 9,000 kg over this year.”

New Flower Products

In the second half of 2021, Decibel will launch a brand-new set of rare cultivars under the Qwest and Qwest Reserve brands.  Frequent rotation of unique genetics that deliver high THC, terpenes and exceptional taste and effect is core to the Qwest Family of Brands product strategy.  The Company expects to launch seven new cultivars in 2021 as well as, a new high THC, pre-milled flower product under the Blendcraft by Qwest Brand.

Qwest Family of Brands

Within the next month Decibel will begin the roll out of its new cultivar and dried flower program across all registered provinces:

• Qwest Reserve Sunset MAC a cross of Sunset Sherbet and MAC1 with the first lot at 28.5% THC
• Qwest Stuffed French Toast a cross of Cookies & Cream and French Toast with the first lot at 24% THC
• Blendcraft by Qwest milled flower bag that includes a blend of cultivars with a THC range of 23 – 29%

General Admission

• Entry into the pre-roll category with two SKUs, with General Admission Kootenay Fruit large format, multi-packs

Thunderchild operations are tracking well, and quality remains at Qwest standards as Decibel works towards reaching full run rate production. Early-stage harvests have been slightly above management expectations for yield and harvested crops have tested between 24% – 28.5% THC. Notable operational highlights include:

• Completed the eighth harvest since commencement of operations
• 10 of 20 grow rooms planted and at various stages of cultivation (50% of total facility planted)
• Anticipating run rate of eight harvests per month from the Thunderchild facility by August 2021

New Vape and Concentrate Products

Decibel is committed to consistent innovation and premiumization in the concentrate and vape categories.  The launch of Pressed by Qwest, a concentrate focused brand under the Qwest Family of Brands, allows Decibel to have a format focused brand, concentrate consumers can trust to deliver exceptional quality.

Pressed by Qwest

In June and July, Decibel will begin its roll out of premium live concentrates under Pressed by Qwest across all registered provinces:

• Purple Papaya Gems & Juice (aka. Diamonds & Sauce)
• Apricot Kush Gems & Juice (aka. Diamonds & Sauce)
• Apricot Kush Live Sugar

General Admission

Despite launching early Q4’20, General Admission has achieved 10% market share in Q1’21 through consistent, consumer insight led innovation at approachable pricing.  Live resin vapes will lead premiumization in the vape category with General Admission at the forefront.

• Kootenay Fruit Live Resin Vape launched in AB, BC, SK in May, and ON in July
• Guava Chemdawg Live Resin Vape launching in July

Link to Decibel’s Investor Presentation

About Decibel

Decibel is uncompromising in the process and craftsmanship needed to deliver the highest quality cannabis products and retail experiences. Decibel has three operating production houses along with its wholly owned retail business, Prairie Records. The Qwest Estate in Creston, BC is a licensed and operating 26,000 square foot cultivation space which produces the widely championed, rare cultivar-focused brands Qwest and Qwest Reserve, which are sold in six provinces across Canada. Thunderchild Cultivation, is a licensed and operating 80,000 square foot indoor cultivation facility in Battleford, SK. The Plant, Decibel’s extraction facility, in Calgary, AB has 15,000 square feet of Health Canada licensed extraction and product development space. This production house will fuel the growth of our brands Qwest, Qwest Reserve, and Blendcraft, into new and innovative product formats like concentrates, vapes, edibles and beyond.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements

Forward Looking Information

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.

In this news release, forward-looking statements relate to, among other things, the company’s product release expectations and plans, the anticipated increase to the Company’s flower capacity and the timing thereof, Decibel’s launch a of brand-new set of rare cultivars under the Qwest and Qwest Reserve brands and the timing thereof, the Company expectation that it will launch seven new cultivars in 2021 as well as, a new high THC, pre-milled flower product under the Blendcraft by Qwest Brand, the Company’s expectation that, within the next month, Decibel will begin the roll out of it’s new cultivar and dried flower program across all registered provinces, the anticipated run rate of harvests per month from the Thunderchild facility by August 2021, that Decibel will begin its roll out of premium live concentrates under Pressed by Qwest across all registered provinces and the timing thereof, the Company’s ability to grow Qwest, Qwest Reserve and Blendcraft brands into new and innovative product formats, variations and its other business plans and expectations. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: risks relating to delays, regulatory changes and impacts, capital requirements, construction impacts, displacement requirements and unforeseen requirements resulting from the COVID-19 pandemic, the ability to obtain and maintain licences to retail cannabis products; review of the Company’s production facilities by Health Canada and maintenance of licences (including any amendments thereto) from Health Canada in respect thereof; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the labour market generally and the ability to access, hire and retain employees; general business, economic, competitive, political and social uncertainties; the satisfaction of conditions precedent under the Company’s credit facilities; timing and completion of construction and expansion of the Company’s production facilities and retail locations; and the delay or failure to receive board, regulatory or other approvals, including any approvals of the TSX Venture Exchange, as applicable. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, the Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

These forward-looking statements are made as of the date of this press release and the Company disclaims any intent or obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE Decibel Cannabis Company Inc.

Related Links

https://decibelcc.com/

As the cannabis market moves from the back alley to the boardroom, we are gaining an increasing appreciation for the role genetics play in developing distinct varieties with unique medical and commercial application. As the cannabis market matures, the significance of genetic selection is quickly becoming a focus of the discussion. Cannabis has been loosely regulated in its’ infancy, and the impact of genetics has yet to be fully understood. Companies are now realizing the pivotal role genetics play in producing consistent and quality cannabis.

Cannabis is distinctive, the genetics of each specific strain create a wide-ranging effect all its own. These strains can be similar in many respects, but no two strains are entirely alike. The wide-ranging effects could leave a person lethargic one day and energized the next. This guessing game is not what consumers, dispensaries or regulators want. 

It’s All About The Brand

Many companies in the cannabis industry have yet to establish a brand distinguishing themselves from competitors. Branding serves many purposes including, developing confidence with consumers and building trust that a brand will consistently deliver quality products. This is especially important when you are dealing with psychoactive chemicals like the ones found in the cannabis plant. Each molecule of the plant can create different and varied effects in individuals, based on the genetics of the strain. Flagship brands are highlighting the key role of genetics, when defining a particular strain’s effects, ensuring that the effect is consistent and repeatable.

Click here to receive an Investor Presentation and Company Updates

“The reason that we’re a brand is because we think that is where the safety and authenticity lies for the consumer,” said Charles Phillips, CEO of DNA Genetics, a premier provider of genetics to the cannabis industry. In a recent interview with CFN Media’s Nova Gavers, Phillips states, “From a consumer standpoint, anytime you see “Powered by DNA” on that logo, you’re pretty much going to be understanding that it’s the equivalent of seeing ‘Intel Inside.’ That’s a big deal.”

Charles Phillips, CEO of DNA Genetics, a premier provider of cannabis genetics, believes that the industry still has a long road ahead of them to improve standardized methods of processing.

During the interview with CFN Media, Phillips sheds light on the issue of cannabis patrons purchasing products based upon strains they recognize, but not taking into consideration the brands behind them. Phillips believes the cannabis industry has not placed enough importance on educating people about genetics, standardized operating procedures, and the various effects of strains. Many brands advertise to offer “the same strain” however, the intricate process to produce each strain is unique. The lack of consistency creates a result that may not meet the consumers’ expectations.

For instance, people may go into a dispensary to purchase the cannabis strain, Chocolope, without realizing that the brand is DNA Genetics. Often, the consumer receives Chocolope from another company with dissimilar genetics, resulting in an unexpected experience. DNA Genetics’ ultimate goal is to be recognized as a trusted and consistent source of quality cannabis genetics. They want consumers to rest assured they are receiving the same product with unwavering results, every time they purchase. DNA Genetics’ slogan “Powered by DNA” on the label should be an immediate recognition of quality and consistency for the consumer.

“For us, branding comes into play because we want people to know if they see DNA anywhere on that packaging, whether it be our packaging or whether it be “Powered by DNA” for someone else, you know what you’re going to get. When you are dealing with a psychoactive chemical, that is really important.” – Charles Phillips

Cannabis Passion Exemplified

DNA Genetics is one of the most well-known and regarded cannabis brands in the world. DNA was established over thirteen years ago in Amsterdam by cannabis pioneers, Don Morris and Aaron Yarkoni (“D-n-A”). At the time, it was the only market that provided a place for legal and commercial cannabis activity. Over the years, the Company has built and curated a seasoned genetic library and developed proven standard operating procedures for genetic selection, breeding, and cultivation.

They moved from their homes in California to set up a large grow facility in Amsterdam to perfect their craft before returning to expand in the burgeoning California markets.

Having spent more than a decade building their brand in the European marketplace, DNA has simultaneously been developing strategic partnerships throughout the world. DNA is poised to enter all legal markets as the laws in each territory change to provide for legal cannabis enterprises. DNA is positioned to become the first genuinely geographically-diversified Company, with multiple partnerships of top-licensed producers and brands. These producers and brands have built their companies and global presence utilizing the “Powered by DNA” model”. DNA Genetics’ intentions have not changed from the moment the company was created. Their passion for the genetics of cannabis and commitment to quality has been unwavering.

Click here to receive an Investor Presentation and Company Updates

Don Morris and Aaron Yarkoni, co-founders of DNA Genetics have been recognized for their many contributions to the cannabis industry. They were named as part of High Times’ 100 Most Influential People in Cannabis. They were also awarded the High Times Trail Blazers Award for contributions made towards uniting the fields of entrepreneurship, politics and medicine. The brand has been considered a genetics powerhouse with best-in-class cultivars for over a decade. DNA Genetics has amassed more than 200 global cannabis awards during the course of their career.

Their vision and work have not only earned them industry accolades, but also a partnership with Canopy Growth Corp. (NYSE: CGC) (TSX: WEED), the largest cannabis company in the world. In 2015, the two companies partnered to collaborate and develop world-class cannabis for their first agreement in the Canadian market. DNA provided Canopy with unique and genetically-diverse strains that were incorporated into Canopy’s Canadian product lines.

In March 2017, the partnership between Canopy Growth and DNA was renewed and expanded, into Jamaica, Germany, and other international markets. Under the terms of the announcement, Canopy Growth and DNA committed to working together through 2024. They will continue to make every effort to expand into global markets, including Europe, where regulations permit the legal sale of cannabis for medical and recreational purpose.

Charles Phillips, CEO of DNA Genetics, explains that DNA is only interested in working with top notch companies that share the same commitment to quality. Only teaming with fully vetted partners to share in revenue streams, the company can ensure it expands globally in a responsible and efficient manner. He emphasizes that shareholders are investing in heritage and legacy companies, with highly efficient capital expenditure models and a knowledgeable management team like DNA Genetics.

Phillips states, “From an investor standpoint, it is really helpful because you know we are going to work with vetted partners and we are going to be partnering with them in terms of revenue recognition and licensing revenue. That is pretty easily supported by what we are telling them. You have another signifier to verify the forecast we are giving you. More importantly, it is really an efficient use of capital.”

Charles Phillips and the “DNA Army” place great importance on the industry foundation being built upon informative discussions about cannabis and how it affects people. He believes education is the key component to achieving a successful, safe, and well-rounded industry.

Click here to receive an Investor Presentation and Company Updates

For Additional Information on DNA Genetics please visit the website at dnagenetics.com

The above article is sponsored content.

Please follow the link below to view our full disclosure outlining our compensation: https://www.cannabisfn.com/legal-disclaimer.

Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox

About Ash Stringer